Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Eugenol efficacy in preventing nicotine-induced seizures in mice

Neda Sistani Karampour, Ardeshir Arzi, Soroor Namazifar.




Abstract

Background: Seizure is the most common neurological disorder after stroke. In fact, the seizure is a chronic neurological disorder affected 1-2% of the global population. Given the side effects and toxicity of synthetic drugs, some herbal medicines are currently used in the treatment of seizure.

Aims and Objectives: The aim of this study was to evaluate the effect of Eugenol, a compound extracted from clove plant, which is effective in preventing nicotine-derived seizures in mice.

Materials and Methods: In this study, 64 mice were randomly selected. In the dose-response study, different doses of Eugenol (400, 600, and 800 mg/kg) were intraperitoneally injected to the experimental groups. The negative and positive control groups, respectively, received saline (10 ml/kg) and diazepam (0.15 mg/kg). After 30 min, the animals in all groups received intraperitoneal injections of nicotine (5 mg/kg) followed by the measurements of onset time, duration, and severity of seizures. In time-response examination, the most effective dose of Eugenol (600 mg/kg) was injected into the animals at 15, 30, 45, and 60 min before nicotine injection. Afterward, the onset, severity, and duration of seizure were determined.

Results: The results of the dose-response test showed that Eugenol doses of 400, 600, and 800 mg/kg resulted in increased time of onset, and reduced severity and duration of seizure compared to the saline group. The results of time-response revealed that the best dose was 600 mg/kg and that the best time for Eugenol injection was in 30 min before injection of nicotine.

Conclusion: The results of this study suggest that Eugenol can be effective in controlling nicotine-induces seizures.

Key words: Eugenol; Nicotine; Seizures; Mice






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.